STOK - Balance Sheet - Stoke Therapeutics, Inc.

Current Liabilities	40.1 M
Accounts Payable	2.5 M
Short-Term Debt	2.32 M
Other Current Liabilities	35.2 M
Non-Current Liabilities	2.48 M
Long-Term Debt	0
Other Non-Current Liabilities	2.48 M

Millions

	Dec-2024	Dec-2023	Dec-2022	Dec-2021	Dec-2020	Dec-2019	Dec-2018	Dec-2017
ASSETS
Cash & Cash Equivalents	128.0	191.4	113.6	144.9	287.3	222.5	105.4	1.8
Short Term Investments	88.9	10.0	116.0	74.9	0	0	0	0
Receivables	0.7	64 K	0.6	0.1	6 K	0.3	0.2	0
Inventory	0	0	10.9	0	0	0	0	0
Other Current Assets	15.2	13.9	13.9	9.3	6.6	6.6	0.5	0.1
Total Current Assets	232.8	215.3	244.1	229.2	293.9	226.0	106.1	1.9
PP&E	8.3	12.4	11.4	9.1	3.8	2.5	1.2	0.5
Intangible Assets	0	0	0	0	0	0	0	0
Goodwill	0	0	0	0	0	0	0	0
Long Term Investments	0	0	0.6	0.6	0.2	0.2	0.2	56 K
Other Long Term Assets	30.5	0.6	0	0	0	0	0	0
Other Assets	0	0	0	0	0	0	0	0
Total Assets	271.6	228.3	256.1	238.9	297.9	228.8	107.5	2.4
LIABILITIES
Accounts Payable	2.5	1.7	0.8	2.4	1.5	0.8	1.1	0.1
Short Term Debt	2.3	2.4	2.4	1.5	1.1	0	0	3.0
Other Current Liabilities	16.2	11.8	13.4	13.2	8.9	3.4	1.4	0.6
Total Current Liabilities	40.1	30.8	31.4	17.1	11.4	4.1	2.5	3.7
Long Term Debt	0	0	0	0	0	0	0	0
Deferred Tax Income	0	0	(2.7)	0	0	0	0	0
Other Liabilities	2.5	4.9	3.0	3.9	0.4	0.2	4 K	16 K
Total Liabilities	42.5	68.8	71.2	21.1	11.8	4.3	2.5	3.7
EQUITY
Common Stock	5 K	5 K	4 K	4 K	4 K	3 K	1 K	1 K
Retained Earnings	(490.8)	(401.8)	(297.1)	(196.1)	(110.3)	(58.0)	(25.7)	(13.2)
Other Accumulative Comprehensive Income/Loss	(0.2)	24 K	(1.2)	(0.2)	0	0	(0.4)	(0.2)
Total Equity	229.0	159.6	184.8	217.8	286.1	224.4	105.1	(1.3)
Total Liabilities and Equity	271.6	228.3	256.1	238.9	297.9	228.8	107.5	2.4
SHARES OUTSTANDING
Common Shares Outstanding	54.0	44.0	38.9	36.7	33.5	18.0	23.5	12.8

Free